Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1967 6
1968 3
1969 3
1970 3
1971 6
1974 1
1977 2
1979 2
1980 1
1981 1
1982 2
1983 4
1984 4
1985 3
1986 3
1987 12
1988 7
1989 9
1990 13
1991 4
1992 2
1993 3
1994 7
1995 3
1996 4
1997 6
1998 4
1999 1
2000 4
2001 7
2002 5
2003 3
2004 5
2005 6
2006 10
2007 13
2008 6
2009 5
2010 8
2011 10
2012 10
2013 10
2014 14
2015 19
2016 10
2017 7
2018 7
2019 8
2020 11
2021 7
2022 7
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Results by year

Filters applied: . Clear all
Page 1
[Adrenal hemorrhage].
Waki M. Waki M. Nihon Rinsho. 2006 May 28;Suppl 1:566-9. Nihon Rinsho. 2006. PMID: 16776217 Review. Japanese. No abstract available.
Febuxostat and renal outcomes: post-hoc analysis of a randomized trial.
Kohagura K, Kojima S, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Hiramitsu S, Waki M, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Sugawara M, Mori H, Tsujita K, Matsui K, Hisatome I, Ohya Y, Kimura K, Saito Y, Ogawa H; Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators. Kohagura K, et al. Among authors: waki m. Hypertens Res. 2023 Jun;46(6):1417-1422. doi: 10.1038/s41440-023-01198-x. Epub 2023 Feb 7. Hypertens Res. 2023. PMID: 36750608 Clinical Trial.
Development of imaging mass spectrometry.
Saito Y, Waki M, Hameed S, Hayasaka T, Setou M. Saito Y, et al. Among authors: waki m. Biol Pharm Bull. 2012;35(9):1417-24. doi: 10.1248/bpb.b212007. Biol Pharm Bull. 2012. PMID: 22975490 Free article. Review.
Dasatinib-induced colitis: clinical, endoscopic and histological findings.
Yamauchi K, Inaba T, Colvin HS, Sakakihara I, Yamamoto K, Izumikawa K, Takahashi S, Tanaka S, Ishikawa S, Wato M, Ando M, Waki M. Yamauchi K, et al. Among authors: waki m. Scand J Gastroenterol. 2022 Apr;57(4):449-456. doi: 10.1080/00365521.2021.2022190. Epub 2022 Jan 1. Scand J Gastroenterol. 2022. PMID: 34978242
Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease.
Konishi M, Kojima S, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Hiramitsu S, Waki M, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Sugawara M, Mori H, Tsujita K, Matsui K, Hisatome I, Ohya Y, Kimura K, Saito Y, Ogawa H; Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators. Konishi M, et al. Among authors: waki m. Int J Cardiol. 2022 Feb 15;349:127-133. doi: 10.1016/j.ijcard.2021.11.076. Epub 2021 Dec 3. Int J Cardiol. 2022. PMID: 34864084 Clinical Trial.
Rationale and design of the EMPYREAN study.
Motoki H, Masuda I, Yasuno S, Oba K, Shoin W, Usami S, Saito Y, Waki M, Komatsu M, Ueshima K, Nakagawa Y, Son C, Yonemitsu S, Hiramitsu S, Konda M, Onishi K, Kuwahara K. Motoki H, et al. Among authors: waki m. ESC Heart Fail. 2020 Oct;7(5):3134-3141. doi: 10.1002/ehf2.12825. Epub 2020 Jun 23. ESC Heart Fail. 2020. PMID: 32578353 Free PMC article. Clinical Trial.
Discovery of Carbono(di)thioates as Indoleamine 2,3-Dioxygenase 1 Inhibitors.
Kumazawa M, Tejima M, Fukuda M, Takeda S, Suzuki K, Mizumoto Y, Sato K, Waki M, Miyachi H, Asai A, Takikawa O, Hashimoto T, Ohno O, Matsuno K. Kumazawa M, et al. Among authors: waki m. ACS Med Chem Lett. 2021 Jan 15;12(2):211-216. doi: 10.1021/acsmedchemlett.0c00527. eCollection 2021 Feb 11. ACS Med Chem Lett. 2021. PMID: 33603967 Free PMC article.
287 results